Promoted Content
Promoted Content

Overview of Omeprazole

Client Email Product
Omeprazole
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
19

API Market Place

INTERMEDIATES
DOSSIERS
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES
  • FDA
  • EDQM
Applications: Mannogem (Mannitol Powder) dissolves rapidly and can increase the rate of tablet disintegration, subsequent drug dissolution and drug release.
Ingredient(s): Mannitol
Dosage Form: Granule / Pellet, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Maize starch and Microcrystalline Cellulose
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Pharmatose® 200M is a highly consistent monohydrate lactose which delivers good compaction properties.This lactose type is typically used in tablets, capsules and extrusion spheronisation.
Ingredient(s): Lactose Monohydrate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph
Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46
  • WHO-GMP
Applications: Blend homogeneity even for low dose and micronized API’s, No need of other auxillary excipients
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP-NF
Technical Specifications: Microcrystalline Cellulose and Colloidal Silicon Dioxide
  • FDA
  • EDQM
Applications: Moisture barrier, Multi particulates, Dry powder layering, Granulation, Hot melt extrusion, Taste Masking, Controlled / Modified Release
Ingredient(s): EthylCellulose
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry Granulation
Ingredient(s): Lactose Monohydrate
Route of Administration (Grade): Oral
Pharmacopoeia Reference: IP, BP, USP-NF
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct Compression, Dry Granulation
Ingredient(s): Anhydrous Lactose
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Maize starch and Lactose anhydrous